Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2, PHASE3
Sponsor: Mirati Therapeutics Inc.
Condition: Advanced or Metastatic Solid Malignancies
NCT04887870
Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Completed No Results Found Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.